When a company comes up with something better, it typically wants a high profile for the technology. But it’s not always the case with Focal Therapeutics.
That’s because the company recently launched a low-profile version of the BioZorb® implant used in breast conservation treatment (BCT).
Focal’s new BioZorb LP (for “low-profile”) design means more women who need breast cancer surgery could benefit from the implantable device. BioZorb is used in “reconstructive lumpectomy” and other types of BCT. It marks in three dimensions the site from which a breast tumor is removed.
The BioZorb LP device is designed to be implanted in smaller breasts, peripheral areas of the breast, and locations with less tissue coverage.
“Everyone understands the need for delivering more personalized medicine,” said Alison Laidley, M.D., a prominent Dallas breast surgeon with Texas Breast Specialists who was among the first physicians to use BioZorb LP. “The new designs of this device enable us to provide it to many more patients.” Continue reading “When a ‘Low Profile’ Is a Good Thing”